Navigation Links
The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide 'Call for Proposals' From Life Science Technologies in Need of Funding and Active Management
Date:2/1/2010

AURORA, Colo., Feb. 1 /PRNewswire/ -- The Colorado Institute for Drug, Device and Diagnostic Development (CID4) launches this month with a statewide "Call for Proposals" from Colorado life science technologies in need of funding and active management.  The announcement is made by Kevin M. Smith, CID4 Executive Vice President/COO and spokesperson.

"With more than 20,000 good-paying jobs in Colorado, the life sciences industry is one of our state's most important economic sectors today and it holds incredible promise for tomorrow," Colorado Gov. Bill Ritter said.

CID4 was formed through the collaborative efforts of all sectors of the Colorado Life Science community to bridge the gap between basic research and successful product commercialization, thereby creating more Colorado jobs in the life science industry.

"We are very excited about this opportunity to continue developing Colorado's life science sector.  With initial financial support in the form of grants from the State of Colorado and Fitzsimons Redevelopment Authority, we have been able to commence operations, recruit a highly distinguished Technical and Business Advisory Committee and reach out to sources of technology across the State," Richard C. Duke, CID4 President & CEO, explains.  

"By helping promising technologies in need of startup assistance to become great companies, CID4 becomes our secret weapon to growing more, higher-paying Colorado jobs" The Honorable Ed Tauer, Mayor of the City of Aurora says.

About the First Solicitation

CID4 invites Colorado-based Technology Transfer Offices (TTOs), researchers and inventors from Colorado-based public and private not-for-profit research Institutions, independent researchers and inventors in Colorado, and private Colorado-based Life Science Companies to submit technologies for consideration. For deadline information and submission form, visit: http://www.cid4.com/downloads/CID4_technology_012710.pdf

About The Colorado Institute for Drug, Device and Diagnostic Development

CID4 is transforming life science innovation into commercial success by identifying and funding potential opportunities, and utilizing the talents of an advanced leadership team to ensure ultimate market value.  For more information, visit http://www.cid4.com.

SOURCE The Colorado Institute for Drug, Device and Diagnostic Development

RELATED LINKS
http://www.cid4.com/

'/>"/>

SOURCE The Colorado Institute for Drug, Device and Diagnostic Development
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Colorado Medical School Receives Provisional Accreditation
2. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
3. Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards
4. Colorado Doctors of Chiropractic Win Awards
5. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association
6. Announcing Always Best Care Senior Services Expansion Into the Littleton/Denver, Colorado Area
7. Announcing Always Best Care Senior Services Expansion into Colorado Springs, Colorado
8. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
9. Colorado Casinos Clear the Air and Become Smoke-Free in 2008
10. American Life League Praises Colorado Efforts to Stop Planned Parenthood Abortion Facility
11. JDRF to establish an autoimmunity center at University of Colorado Denver
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce ... a longtime supporter of the event. , "We are pleased that KLS Martin is ... Havlik, 2017 ACPA President. "KLS Martin has a long track record of support of ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare ... for those in the fight against cancer, has produced a seminal study that ... HRA will release top-line findings in a webinar, Defining Compassionate Care Through the ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
Breaking Medicine Technology: